- Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancerDonald Lamm
BCG Oncology, P C, Phoenix, AZ Electronic address
Urol Oncol 32:35.e21-30. 2014..In this article, we review the various options for and the potential role of interferon alfa (IFN-α) in the treatment of non-muscle-invasive bladder cancer (NMIBC)...
- Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definitionDonald Lamm
Department of Surgery, University of Arizona and BCG Oncology, Phoenix, Arizona Electronic address
J Urol 191:20-7. 2014..We examine current definitions of nonmuscle invasive bladder cancer progression, and propose a new definition that will be more clinically useful in determining patient prognosis and comparing treatment options...